Takeda Pharmaceuticals: Global Homepage

With employees at our Oranienburg, Germany, manufacturing facility

Shareholder Letter from CEO-Elect Julie Kim

Meet Julie Kim

Julie Kim brings more than three decades of global health care experience and a reputation for advancing innovation, expanding access to life-changing medicines and delivering meaningful impact for patients and communities.

LEARN MORE ABOUT JULIE

Recent News

Takeda Provides an Update regarding Jury Verdict in AMITIZA® (lubiprostone) Antitrust Litigation in the U.S. and Related Revision to FY2025 Financial Results

May 19, 2026

Continuation of the Stock Compensation Plan for Directors and the Stock Grant System for Company Management in Japan in 2026

May 13, 2026

Takeda Announces FY2025 Full Year Results and FY2026 Outlook, Highlighted by Excellent Pipeline Progress and Solid FY2025 Results

May 13, 2026

Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)

May 4, 2026

VIEW ALL

We exist to create better health for people and a brighter future for the world. While the science and technology we advance are constantly evolving, our ambition remains. We move science forward, so we can transform more lives.

Better Health, Brighter Future

Our Areas of Focus

Gastrointestinal and Inflammation

Understanding and addressing life-limiting gastrointestinal and inflammatory diseases

Rare Diseases

Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders

Plasma-Derived Therapies

Improving the lives of patients with rare and complex chronic diseases through innovation in plasma

Oncology

Aspiring to cure cancer, with inspiration from patients and innovation from everywhere

Neuroscience

Driving medical innovation for patients with neurological diseases

Vaccines

Addressing unmet global health needs through vaccine development against infectious diseases

Sign up for investors newsletter

Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet

SIGN UP